SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-005939
Filing Date
2018-01-29
Accepted
2018-01-29 19:51:19
Documents
1
Period of Report
2018-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5704
  Complete submission text file 0001209191-18-005939.txt   7369
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 225 S. LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address
Li Zhen (Reporting) CIK: 0001729510 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38042 | Film No.: 18557243